1: Zhang J, Wang Y. Bilobetin, a novel small molecule inhibitor targeting influenza virus polymerase acidic (PA) endonuclease was screened from plant extracts. Nat Prod Res. 2021 Dec;35(24):5968-5971. doi: 10.1080/14786419.2020.1808636. Epub 2020 Aug 21. 34(4):e4784. doi: 10.1002/bmc.4784. Epub 2020 Jan 20. 10(5):1134. doi: 10.3390/biomedicines10051134. 4: Wang Q, Wu ZL, Yuan X, Dong HY, Xu X, Xin H, Wang YH, Zhang JB, Chen L, Li HL, Zhang XM, Zhang WD. Bilobetin induces kidney injury by influencing cGMP- mediated AQP-2 trafficking and podocyte cell cycle arrest. Phytomedicine. 2019 Nov;64:153073. doi: 10.1016/j.phymed.2019.153073. Epub 2019 Aug 23. 22(5):22-30. doi: 10.2174/1871526522666220321152036. 165(8):2692-706. doi: 10.1111/j.1476-5381.2011.01727.x. 7: Feng X, Zhang X, Chen Y, Li L, Sun Q, Zhang L. Identification of bilobetin metabolites, in vivo and in vitro, based on an efficient ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry strategy. J Sep Sci. 2020 Sep;43(17):3408-3420. doi: 10.1002/jssc.202000313. Epub 2020 Jul 8.
合成参考文献
参考文献:10.1021/jf011682s 摘要:Bedir E, Tatli II, Khan RA, Zhao J, Takamatsu S, Walker LA, Goldman P, Khan IA. Biologically active secondary metabolites from Ginkgo biloba. J Agric Food Chem. 2002 May 22;50(11):3150–5. doi: 10.1021/jf011682s. 参考文献:10.1038/s41592-019-0358-2]